Device/Combo Products: UDI vs Serialization Alignment



Device/Combo Products: UDI vs Serialization Alignment

Published on 10/12/2025

Device/Combo Products: UDI vs Serialization Alignment

1. Understanding Unique Device Identification (UDI) and Serialization

The pharmaceutical and medical device industries are under constant pressure to enhance traceability and ensure patient safety. Understanding the key concepts of Unique Device Identification (UDI) and serialization plays a crucial role in compliance and operational efficiency. UDI provides a unique identifier for medical devices, facilitating tracking and identification throughout the supply chain. Serialization, on the other hand, involves assigning unique serial numbers to individual units of products, enabling effective tracking from production through distribution to the end user.

In the context of regulatory compliance, organizations must align their UDI systems with serialization requirements to ensure that they meet international standards, including those set forth by FDA, EMA, and the UK’s MHRA. Understanding these guidelines is essential for developing robust serialization and aggregation systems.

Key benefits include enhanced visibility into the supply chain, improved inventory management, and compliance with regulations such as the Drug Supply Chain Security Act (DSCSA) in the United States, and the European Falsified Medicines Directive (EU FMD) in Europe. This comprehensive overview lays a foundation for aligning UDI initiatives with serialization efforts.

2. Guidelines for Creating a Unified Requirements Specification (URS)

A well-defined User Requirements Specification (URS) is critical in ensuring that the serialization and UDI alignment process is met effectively. This document serves as the foundation for all subsequent validation activities, ensuring stakeholder expectations are documented and the necessary functionality is delineated.

Begin by assembling cross-functional teams that include representatives from quality assurance (QA), regulatory affairs, clinical operations, and IT. This collaboration ensures that all relevant perspectives are incorporated into the URS. The URS should cover essential areas, including:

  • Device Definitions: Clearly define the boundaries of devices and combinational products covered under the UDI and serialization policies.
  • Disposition Workflows: Detail the processes for how devices will be serialized and aggregated throughout the supply chain.
  • Data Integrity and Security: Define requirements ensuring that data integrity principles, such as ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, and Complete), are adhered to.
  • Change Control Processes: Include procedures for managing changes to the UDI and serialization systems to meet evolving regulations.

This comprehensive URS will guide system design and implementation and will inform validation plans and protocols for both serialization and aggregation.

3. Master Data Governance and Flows

Effective master data governance is essential for the successful implementation of serialization and UDI alignment initiatives. Master data includes all critical data elements that support business processes, such as product hierarchies, device attributes, and trade item references.

To establish a successful master data governance framework, organizations should follow these steps:

  • Define Master Data Elements: Identify key data attributes needed for serialization and UDI compliance, ensuring that they meet regulatory standards.
  • Establish Governance Policies: Draft policies defining how master data will be created, maintained, and accessed. This includes setting roles and responsibilities.
  • Implement Data Quality Controls: Outline procedures for routine data quality checks to ensure accuracy, timeliness, and consistency of master data.
  • Interface Validation: Ensure that interfaces between systems (such as ERP, WLMS, etc.) that handle master data comply with previous definitions.

Properly managing master data can minimize communication gaps among departments and support a streamlined serialization and aggregation process, ultimately improving compliance with WHO guidelines.

4. Line/Level Qualification and Reconciliation

Line/level qualification is a crucial step for ensuring that the production lines responsible for serialization and aggregation are compliant and operate as intended. This process involves validating equipment and systems to guarantee they can perform as required.

To begin the qualification process, you should adopt the following structured approach:

  • Define Qualification Scope: Determine which equipment (e.g., serialization and aggregation lines) need qualification, focusing on those that impact UDI compliance.
  • Develop Qualification Protocols: Create Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) protocols to validate equipment.
  • Execute Qualification Tests: Conduct tests as per the established protocols, documenting results carefully to create a robust audit trail.
  • Reconciliation Rules: After qualification, develop reconciliation processes to compare serialized data with physical inventory regularly. This will help prevent discrepancies.

By adhering to line/level qualification principles, organizations can ensure that their production and packaging systems remain compliant with regulatory expectations and can seamlessly integrate UDI and serialization processes.

5. Exception Handling and Rework Strategies

Within any serialization and aggregation process, exceptions and reworks are inevitable. Establishing a clear strategy for exception handling will ensure that the organization can maintain compliance while minimizing delays in production.

The following steps can serve as a framework for developing an effective exception handling plan:

  • Identify Common Exceptions: Conduct a risk assessment to identify potential exceptions that may arise (e.g., missing serial numbers, incorrect label applications).
  • Define Exception Handling Procedures: Create documented workflows detailing how exceptions should be addressed, including which teams are responsible and the steps involved.
  • Implement Exception Review Processes: Establish regular review meetings to analyze exception cases and revise procedures as necessary. Documentation is crucial for regulatory audits.
  • Develop Rework Cycles: Where rework is necessary, have systems in place to ensure that products are appropriately serialized or aggregated after modifications.

Regular reviews of exception handling processes will also maintain data integrity and compliance with ALCOA+ principles.

6. Audit Trail Review and CAPA

Audit trails are a pivotal component of serialization and UDI compliance, providing a detailed record of the processes and changes made to data throughout the supply chain. Regulatory bodies such as FDA and EMA mandate that organizations maintain comprehensive audit trails to ensure that data can be traced and verified.

The audit trail review process can be broken down into several key steps:

  • Establish Audit Trail Requirements: Document what constitutes a valid audit trail, focusing on data entries, modifications, and system updates.
  • Schedule Regular Audit Reviews: Develop a schedule for conducting routine audits of the audit trails to ensure completeness and accuracy.
  • Implement Corrective and Preventive Actions (CAPA): Should discrepancies be identified, a CAPA plan should be enacted to address the issue, ensuring that future occurrences are minimized.
  • Training and Education: Provide training for personnel on the importance of maintaining audit trails and how to utilize them effectively.

By upholding robust audit trail practices, organizations can safeguard data integrity and facilitate smoother interactions with regulators during inspections.

7. Serialization Change Control and Continuous Improvement

Change control is a crucial process in managing modifications in serialization systems to maintain compliance and ensure system integrity. Establishing effective change control procedures ensures that any alterations in the serialization processes are conducted systematically and documented thoroughly.

Implement a structured approach for serialization change control through the following steps:

  • Identify Changes: Clearly document any changes proposed, including system updates or modifications in workflows.
  • Change Impact Assessment: Assess the potential impact of changes on the existing systems, processes, and regulatory compliance.
  • Approval Processes: Utilize established governance practices to seek approval for changes from all relevant stakeholders.
  • Documentation: Maintain meticulous documentation of all change processes, approvals, assessments, and final outcomes to ensure traceability and transparency.

Continuous improvement should be a mantra within organizations. Regularly reviewing systems and identifying opportunities for improvement creates efficiencies, enhances compliance with serialization requirements, and enhances overall data integrity. A culture of quality and compliance can profoundly affect organizational success in the long term.

Conclusion

Aligning Unique Device Identification (UDI) with serialization requires a collaborative, systematic approach that incorporates the entire organization’s inputs and expertise. By carefully following the steps outlined in this article, from developing a robust URS to implementing effective master data governance, organizations can navigate the complexities of serialization and aggregation while striving for continuous improvement. Through disciplined qualification, well-managed exception handling, thorough audit trail reviews, and stringent change control processes, compliance with regulatory demands such as DSCSA and EU FMD can be maintained, ensuring the integrity of the pharmaceutical supply chain.